Intratympanic treatment of intractable unilateral ménière disease: Gentamicin or dexamethasone? A randomized controlled trial

Otolaryngology - Head and Neck Surgery

Volumn 146, Issue 3, 2012, Pages 430-437

  Casani, Augusto Pietro ^a   Piaggi, Paolo ^b   Cerchiai, Niccolò ^a   Seccia, Veronica ^a   Franceschini, Stefano Sellari ^a   Dallan, Iacopo ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Dexamethasone; Gentamicin; Hearing loss; Intratympanic; M ni re disease; Vertigo

Indexed keywords

DEXAMETHASONE; GENTAMICIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEARING; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; MIDDLE EAR; PURE TONE AUDIOMETRY; SPEECH DISCRIMINATION; VERTIGO;

ADULT; AGED; CHRONIC DISEASE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; HEARING TESTS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MENIERE DISEASE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 84858854358     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811429432     Document Type: Article

References (41)

1. Rauch SD. Clinical hints and precipitating factors in patients suffering from Ménière's disease. Otolaryngol Clin North Am. 2010;43:1011-1017.
2. Pullens B, van Benthem PP. Intratympanic gentamicin for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2011;(3):CD008234. doi:10.1002/14651858.CD008234.pub2.
3. Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Méniere's disease: a metanalysis. Laryngoscope. 2004;114:2085-2091. (Pubitemid 39602470)
4. Nedzelsky JM, Chiong CM, Fradet G, et al. Intratympanic gentamicin instillation as treatment of unilateral Ménière's disease: update of an ongoing study. Am J Otol. 1993;14:278-282. (Pubitemid 23155879)
5. Kaplan DM, Nedzelsky JM, Chen JM, et al. Intratympanic gentamicin for the treatment of unilateral Ménière's disease. Laryngoscope. 2000;110:1298-1305. (Pubitemid 30626096)
6. Sennaroglu L, Sennaroglu G, Gursel B, Mottaghian Dini F. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Ménière's disease. Otolaryngol Head Neck Surg. 2001;125:537-543. (Pubitemid 33662703)
7. Longridge NS, Mallinson AI. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease. J Otolaryngol. 2000;29:35-39. (Pubitemid 30120557)
8. Harner SG, Drisco CL, Facer GW, et al. Long-term follow-up of transtympanic gentamicin for Meniere's syndrome. Otol Neurotol. 2001;22:210-214. (Pubitemid 32233476)
9. Quaranta A, Scaringi A, Aloidi A, Quaranta N, Salonna I. Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol. 2001;121:387-392. (Pubitemid 32472995)
10. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol. 2004;25:544-552. (Pubitemid 39079778)
11. Ruckenstein MJ. Immunological aspects of Ménière's disease. Am J Otolaryngol. 1999;20:161-165.
12. Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol. 2007;28:1124-1130. (Pubitemid 350191089)
13. Pondugula SR, Raveendran NN, Ergonul Z, et al. Glucocorticoid regulation of genes in the amiloride sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat. Physiol Genomics. 2006;24:114-123.
14. Trune DR, Kempton JB, Gross ND. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res. 2006;212:22-32. (Pubitemid 43254933)
15. Fukushima M, Kitahara T, Fuse Y, et al. Changes in aquaporin expression in the inner ear of the rat after i.p. injection of steroids. Acta Otolaryngol Suppl. 2004;553:13-18. (Pubitemid 39093370)
16. Shirwany NA, Seidman MD, Tang W. Effects of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity and histology in guinea pigs. Am J Otol. 1998;19:230- 235.
17. Otake H, Yamamoto H, Teranishi M, Sone M, Nakashima T. Cochlear blood flow during occlusion and reperfusion of the anterior inferior cerebellar artery: effect of topical application of dexamethasone to the round window. Acta Otolaryngol. 2009;129:127-131.
18. Itoh A, Sakata E. Treatment of vestibular disorders. Acta Otolaryngol Suppl. 1991;481:617-623.
19. Shea JJ Jr., Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease. Otolaryngol Clin North Am. 1996;29:353-358. (Pubitemid 26138064)
20. Garduno-Anaya MA, Couthino DT, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, doubleblind, randomized trial. Otolaryngol Head Neck Surg. 2005; 133:285-294. (Pubitemid 41125682)
21. Boleas-Aguirre MS, Della Lin FR, Santina CC, Minor LB, Carey JP. Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease. Otol Neurotol. 2008;29:33-38.
22. Herraiz C, Plaza G, Aparicio JM, et al. Transtympanic steroids for Ménière's disease. Otol Neurotol. 2010;31:162-167.
23. Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S. Dexamethasone inner ear perfusion for the treatment of Ménière's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19:196-201. (Pubitemid 28152576)
24. Barrs DM, Keyser JS, Stallworth C, McElveen JT Jr. Intratympanic steroid injections for intractable Ménière's disease. Laryngoscope. 2001;111:2100-2104. (Pubitemid 33117204)
25. Barrs DM. Intratympanic injections of dexamethasone for long-term control of vertigo. Laryngoscope. 2004;114:1910- 1914.
26. Hirvonen TP, Peltomaa M, Ylikoski J. Intratympanic and systemic dexamethasone for Ménière's disease. ORL J Otorhinolaryngol Relat Spec. 2000;62:117-120. (Pubitemid 30248561)
27. Dodson KM, Woodson E, Sismanis A. Intratympanic steroid perfusion for the treatment of Ménière's disease: a retrospective study. Ear Nose Throat J. 2004;83:394-398. (Pubitemid 39090450)
28. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg. 1995;113:181-185.
29. Schulz KF, Altman DG, Moher D, CONSORT Group-CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trial. Ann Int Med. 2010;152:726-732.
30. Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Ménière disease. Otolaryngol Head Neck Surg. 1989;100:6-16. (Pubitemid 19046900)
31. Quaranta A, Marini F, Sallustio V. Long-term outcome of Ménière disease: endolymphatic mastoid shunt versus natural history. Audiol Neurotol. 1998;3:54-60. (Pubitemid 28055204)
32. Green JD Jr, Blum DJ, Harner SG. Longitudinal follow-up of patients with Ménière disease. Otolaryngol Head Neck Surg. 1991;104:783-788.
33. Coelho DH, Lalwani AK. Medical management of Ménière's disease. Laryngoscope. 2008;118:1099-1108.
34. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109:1-17. (Pubitemid 29315126)
35. Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol. 2006;27:564-569.
36. Mynatt R, Hale SA, Gill RM, Plontke SK, Salt AN. Demonstration of a longitudinal concentration gradient along scala tympani by sequential sampling of perilymph from the cochlear apex. J Assoc Res Otolaryngol. 2006;7:182-193. (Pubitemid 43800627)
37. Hillman TM, Arriaga MA, Chen DA. Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops? Laryngoscope. 2003;113:1903-1907. (Pubitemid 37409673)
38. Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss. Otol Neurotol. 2005;26: 890-895. (Pubitemid 41330703)
39. Zhai F, Liu JP, Dai CF, Wang Q, Steyger PS. Evidencebased modification of intratympanic gentamicin injections in patients with intractable vertigo. Otol Neurotol. 2010;31:642- 648.
40. Pender DJ. Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol. 1985;6:358-367. (Pubitemid 16223550)
41. Hu A, Parnes LS. Intratympanic steroids for inner ear disorders: a review. Audiol Neurotol. 2009;14:373-382.